Last reviewed · How we verify
Prevention of Radiation-Induced Nausea and Vomiting
Approved treatments
- Estron · Watson Labs
- GRAN® · EVIVE Biotechnology
- Zofran · GSK (originally Glaxo)
Selective 5-HT3 receptor antagonist that blocks serotonin-mediated nausea and vomiting signals in the CTZ and vagal afferents.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of Radiation-Induced Nausea and Vomiting patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of Radiation-Induced Nausea and Vomiting treatment landscape brief
- Prevention of Radiation-Induced Nausea and Vomiting treatment updates RSS
Frequently asked questions about Prevention of Radiation-Induced Nausea and Vomiting
What drugs treat Prevention of Radiation-Induced Nausea and Vomiting?
Tracked treatments include Estron, GRAN®, Zofran.
What is the treatment for Prevention of Radiation-Induced Nausea and Vomiting?
Standard treatment for Prevention of Radiation-Induced Nausea and Vomiting includes Estron, GRAN®, Zofran. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of Radiation-Induced Nausea and Vomiting patent cliff · Prevention of Radiation-Induced Nausea and Vomiting CI report
- Treatment: Estron · Watson Labs
- Treatment: GRAN® · EVIVE Biotechnology
- Treatment: Zofran · GSK (originally Glaxo)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing